Cytovale Secures $100M to Expand Commercialization of FDA-Cleared Sepsis Test
What You Should Know:
– Cytovale, a medical diagnostics company revolutionizing early disease detection secures $100M in Series D funding round led by Sands Capital with participation from new investor Canada Pension Plan Investment Board…
Continue Reading